Keep up to date with the latest news and articles from BMC Psychiatry and BioMed Central.
Email this article to a friend
Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial
J J Sandra Kooij*, Michael Rösler, Alexandra Philipsen, Sandra Wächter, Joachim Dejonckheere, Annemarie van der Kolk, Michel van Agthoven and Barbara Schäuble